Till Eichenauer

Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressive <i><scp>ERG</scp></i> fusion‐positive prostate cancers

Antje Krohn, Annemarie Seidel, Lia Burkhardt et al. · The Journal of Pathology · 2013 · 125 citations

Medicine, Genetics, Oncology +15

Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer

Katharina Möller, Christoph Fraune, Niclas C. Blessin et al. · International Urology and Nephrology · 2021 · 38 citations · Full text

Medicine, Immunology, Oncology +17

Y-chromosome loss is frequent in male renal tumors

Franziska Büscheck, Christoph Fraune, Seyedehmina Garmestani et al. · Annals of Translational Medicine · 2021 · 36 citations · Full text

Medicine, Genetics, Oncology +14

Aberrant expression of membranous carbonic anhydrase IX (CAIX) is associated with unfavorable disease course in papillary and clear cell renal cell carcinoma

Franziska Büscheck, Christoph Fraune, Ronald Simon et al. · Urologic Oncology Seminars and Original Investigations · 2018 · 31 citations

Medicine, Oncology, Pathology +11

Bone Scan Index as an Imaging Biomarker in Metastatic Castration-resistant Prostate Cancer: A Multicentre Study Based on Patients Treated with Abiraterone Acetate (Zytiga) in Clinical Practice

Mariana Reza, Mattias Ohlsson, Reza Kaboteh et al. · European Urology Focus · 2016 · 30 citations

Medicine, Oncology, Urology +17